🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Very grateful for the opportunity to present our work at #ESCCongress in Amsterdam. Responses from a survey distributed by #CCCTN highlight the variability of MCS practices and weaning across academic medical centers in North America. Miguel Alvarez Villela Montefiore Heart Moses-Weiler Internal Medicine Residency

Proud to present our work at #AHA23 in Philadelphia last week. Our INTERMACS analysis looked at outcomes to examine whether patients with a “Cold and Dry” profile derive the same benefit from LVAD therapy. Miguel Alvarez Villela Varrias Dimitrios Safiriyu Israel M.D Moses-Weiler Internal Medicine Residency Montefiore Heart

Chief year ✅ Moses-Weiler Internal Medicine Residency Next stop: Cardiology fellowship 🫀 🩺 Montefiore Heart Thankful for all the lessons learned this past year and excited for what’s to come! #ChiefResident #InternalMedicine #Cardiology #CardiologyFellowship

Excited to start my training in cardiology Montefiore Heart alongside this great group of co-fellows!🫀🩺 😊

Ever wonder what others are doing in the daily management of IABP and Impella @Abiomed? We do too… that’s why we asked CICU directors across the country how they manage these devices. Read: sciencedirect.com/science/articl… CCC Enthusiasts Critical Care Cardiology Trials Network UMN Critical Care Cardiology Education Summit

Heart Failure patients with "cold and dry" profile derive similar benefit from LVAD therapy as "cold and wet" patients Varrias Dimitrios Miguel Alvarez Villela Amrita Balgobind Majd Al Deen #AHAJournals ahajrnls.org/4hx7BBa

There’s a growing number of novel device therapies in heart failure but who’s the right patient for each one? Here we provide a framework to guide pt selection with real world examples of its use Marat Fudim, MD MHS Amrita Balgobind frontiersin.org/journals/cardi…